United States: Cannabis Group Weekly Alert - Week Of June 25, 2019

In this week's edition:

  • The US House passes bipartisan measure to prevent the Department of Justice from interfering with state medical and adult-use cannabis laws.
  • The Supreme Court rules Lanham Act provision preventing registration of trademarks seen as "immoral or scandalous" is an unconstitutional restriction on speech.
  • The Delaware Senate passes legislation making violation of cannabis consumption/possession laws by minors a civil rather than criminal infraction.
  • New Mexico expands medical cannabis program to include protections against discrimination, reciprocity with other states' medical programs, and three-year renewal cycle (up from one) for medial cannabis cards; and
  • Nebraska farmers looking to grow hemp this season have until 5 p.m. Friday to apply to the state Department of Agriculture for a license.


  • A bipartisan coalition of 228 Democratic and 40 Republican House members approved a far-reaching measure to prevent the Department of Justice from interfering with state medical and adult-use cannabis laws. The amendment, which also shields cannabis laws in Washington, DC, and US territories, is part of a large-scale appropriations bill funding parts of the federal government for fiscal year 2020. The House also included amendments transferring $5 million from the Drug Enforcement Administration to opioid treatment programs, and directing the Food and Drug Administration to establish regulations for adding CBD to food and dietary supplements.
  • Before heading home for its July 4 break, the House added to its string of pro-cannabis measures by passing the 2020 Financial Services and General Government bill with a rider to protect banks serving lawful cannabis businesses. Although the amendments represent an unprecedented level of support for pro-cannabis policies in the House, a similar level of support in the Republican-controlled Senate is unlikely.
  • The House Committee on Veterans' Affairs discussed legislation last week that would allow doctors at the US Department of Veterans Affairs (VA) to issue medical cannabis recommendations in states where it's legal. The bill, introduced by Rep. Earl Blumenauer (D-OR) and offered as an amendment to the larger appropriations measure, was pulled when the VA suggested that passage of such a law could create a major liability risk for VA doctors. The panel also took up a bill sponsored by Rep. Lou Correa (D-CA) that would require the VA to conduct clinical trials on the therapeutic potential of cannabis in the treatment of such service-related conditions as post-traumatic stress disorder and chronic pain.
  • On Tuesday, a coalition of 10 senators sent a letter to the heads of the Departments of Justice and Homeland Security calling for an end to a federal immigration policy that bars immigrants who have worked in the state-legal cannabis industry from gaining citizenship. The senators contend that conflicting federal and state cannabis laws "should not be exploited to penalize otherwise law-abiding legal permanent residents who seek to naturalize."
  • Congress has asked vaporizer company JUUL for documents on any partnerships it may have with cannabis companies. JUUL's youth-oriented marketing practices have been the subject of considerable Congressional attention. The City of San Francisco approved an ordinance banning the sale and distribution of e-cigarettes that contain nicotine.
  • The Federal Aviation Administration issued a bulletin clarifying its cannabis and CBD policy for pilots. The FAA stated that pilots who test positive for THC are still disqualified from certain certifications, even if the THC is only from trace amounts in CBD products.
  • The Supreme Court ruled that a century-old provision in federal trademark law preventing businesses from registering trademarks seen as "immoral or scandalous" is an unconstitutional restriction on speech.


  • California regulators are extending the period during which cannabis growers and retailers can operate on provisional permits by five years. The state also announced that it would be increasing enforcement against illegal growers and sellers. Governor Newsom (D) increased funds for enforcement as part of his most recent budget, and jurisdictions have already begun raiding illegal operations. A recent raid in Santa Barbara county resulted in the seizure of 350,000 plants and 20 tons of processed cannabis.
  • The Delaware Senate announced Thursday passage of Senate Bill 45, which would make possession or consumption of cannabis by anyone under 21 years old a civil, rather than criminal, infraction.
  • Hawai`i David Ige (D) announced that HB 1383—decriminalizing possession of three grams or less of cannabis and providing for expungement of criminal records relating to possession of three grams or less—will take effect. However, the Governor is expected to veto a bill that would allow inter-island transfer of medicinal cannabis.
  • Illinois J.B. Pritzker (D) signed the state's cannabis legalization legislation during a ceremony on Tuesday June 25.
  • Louisiana John Bel Edwards (D) signed a bill modifying his state's medical cannabis law to allow patients to inhale medical cannabis and setting fees on sales.
  • Maine Janet Mills (D) signed bills clarifying how medical cannabis dispensaries can become for-profit entities and making technical changes to Maine's cannabis laws.
  • Expansion of the New Mexico's medical cannabis program includes protections from discrimination for patients, reciprocity with other states' medical programs, and an extended life span for medial cannabis cards from one year to three years. Some cannabis providers are also interpreting the new law as expanding the definition of a "qualified patient" to include out-of-state residents, but the state Department of Health is rejecting that interpretation.
  • Oregon Kate Brown (D) has signed legislation, S.B. 970, prohibiting landlords from taking discriminatory action against those who either use medical cannabis or possess cannabis-related convictions.
  • The Utah Department of Agriculture and Food (UDAF) is urging all companies that plan to apply for one of the limited number of licenses to cultivate medical cannabis in the state to start the process of obtaining the required background checks now. Background checks are required of all individuals who have a financial or voting interest of at least two percent, or the power to direct or cause the management or control of the establishment.
  • Washington  regulators announced that the state's new cannabis traceability system will go live on July 15.
  • The Council of the District of Columbia unanimously passed emergency legislation last Tuesday that protects some city employees from employment discrimination for being medical cannabis patients. The legislation comes in response to numerous instances in which city government employees were threatened or penalized for using medical cannabis when not at work. Emergency legislation only requires one council vote (rather than the usual two) and the mayor's signature to become law, but lasts for no longer than 90 days.

Hemp / CBD

  • A Gallup poll found that among Americans who are familiar with CBD, 61 percent want it available over the counter without a prescription required, and 92 percent believe the cannabis-derived compound has at least some medical benefits.
  • In Nebraska, growers looking at the possibility of growing hemp this season can apply for a license with the Nebraska Department of Agriculture. The department announced Friday morning that applications are available online, at nebraska.gov/hemp. Those interested need to move quickly. The window for applying was only a week. The deadline for filing an application is this Friday, June 28, at 5 p.m.
  • According to one CBD retailer, Google is taking steps toward ending its prohibition on advertising for CBD products. The tech giant has initiated a trial program that allows select companies in the nascent hemp sub-industry to purchase ads on its platform. Shedrack Anderson, co-founder of the CBD-infused skincare line Chilyo LP, said last Thursday that Google approached him about being part of a "trial realm" of companies that could purchase advertising on the site through its Google Ads portal. Asked about Anderson's claim, a Google spokesperson reiterated that CBD ads are prohibited on its platform and denied the existence of a trial program.


  • Federal regulators in Canada finalized rules for cannabis edibles, extracts and topicals, with sales set to begin as early as mid-December.
  • Also in Canada, legislation intended to help those convicted of simple possession before recreational cannabis use was made legal received royal assent this past Friday and will soon come into force. By waiving the $631 fee and five- to 10-year waiting period for pardon applications, Bill C-93 removes a major barrier to employment, housing, travel and volunteering opportunities.
  • Canadian federal and provincial governments collected $186 million in tax revenue from the sale of cannabis in the first six months following legalization. The tax earnings came from both excise taxes and general taxes on goods and services (GST).
  • A government-tasked commission has advised France to legalize cannabis to get rid of the black market.


  • The 45-member Global Cannabis Partnership, which includes Canopy Growth Corp. and other companies operating in the sector, issued guidelines aimed at minimizing greenhouse gas emissions and promoting ethical conduct and responsible cannabis use
  • BDS Analytics "State of the Legal Cannabis Markets" found that global legal spending on cannabis will grow to US$40.6 billion in 2024, nearly triple the US$14.9 billion estimated for this year.
  • MTech and MJ Freeway combined to form Akerna Corp., which began trading on Nasdaq on Tuesday.
  • Molson Coors Brewing Co. and Hexo Corp.'s joint venture will start selling cannabis-infused beverages in Canada.
  • Surterra Wellness hired a former Patrón Spirits CEO as its executive director.
  • Blackbird Logistics Corporation announced that is has delivered cannabis products to every licensed cannabis dispensary in California and Nevada—more than 600 retail locations in total.

Medical / Health

  • A California study has found that veterans prefer cannabis to prescription medications or other drugs for treatment of their physical and mental maladies. Researchers from the Department of Veterans Affairs, Harvard Medical School and the University of Pennsylvania surveyed 93 veterans who received donations of medicinal cannabis from the Santa Cruz County, CA-based Santa Cruz Veterans Alliance. The results were published in May in the American Journal of Drug and Alcohol Abuse.
  • A study found that "THC:CBD oromucosal spray proved to be an effective and well-tolerated add-on treatment for patients with elsewhere refractory chronic pain—especially of neuropathic origin."
  • A study on kidney donations concluded that "there was no difference in donor or recipient perioperative characteristics or postoperative outcomes based upon donor marijuana use" and that "considering individuals with a history of marijuana use for living kidney donation could increase the donor pool and yield acceptable outcomes."
  • A newly published study in the Journal of the American Medical Association finds that women who use cannabis during pregnancy could be at higher risk for preterm birth. These studies come as cannabis use among pregnant women is rising, with cannabis dispensaries even marketing the drug as a natural treatment for morning sickness and pain during pregnancy.
  • Herbal cannabis is safe and effective in patients diagnosed with fibromyalgia, according to clinical data published this month in the Journal of Clinical Medicine.
  • A new Colorado study found that "permitting or not permitting recreational cannabis dispensaries in a community does not appear to change student cannabis use or perceptions towards cannabis."
  • A research team analyzing wastewater samples collected between 2013 and 2016 from two treatment plants compared increased THC levels with in-state legal cannabis sales to conclude that legalizing cannabis significantly shifted cannabis use to legal consumption and away from the black market. The report, titled "Using Wastewater-Based Analysis to Monitor the Effects of Legalized Retail Sales on Cannabis Consumption in Washington State, USA," was published in Addiction, a journal published by the Society for the Study of Addiction.

About Dentons

Dentons is the world's first polycentric global law firm. A top 20 firm on the Acritas 2015 Global Elite Brand Index, the Firm is committed to challenging the status quo in delivering consistent and uncompromising quality and value in new and inventive ways. Driven to provide clients a competitive edge, and connected to the communities where its clients want to do business, Dentons knows that understanding local cultures is crucial to successfully completing a deal, resolving a dispute or solving a business challenge. Now the world's largest law firm, Dentons' global team builds agile, tailored solutions to meet the local, national and global needs of private and public clients of any size in more than 125 locations serving 50-plus countries. www.dentons.com.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions